Varinder Singh, MD
Interventional Cardiology · New York, NYNPI 1144214735
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.9%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Heartflow, Inc. at 33.5% of the total. Reporting peaked in 2019 at $12,288 and has fallen 93.2% since, to $838 in 2025.
Across 210 payments — averaging $165.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heartflow, Inc.$12K
- Medtronic$10K
- CSL Behring$3K
- Contego Medical, Inc$2K
- Boston Scientific$2K
- Cardiovascular Systems Inc.$2K
- plus $4K from 12 others
Across 120 payments — averaging $2419.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$221K
- Abbott$69K
What the payments were for
- Consulting fees$8,81325%
- Speaking & faculty fees$8,75025%
- Travel & lodging$2,5997%
- Food & beverage$14,51642%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heartflow, Inc. | 11 | $11,612 |
| Medtronic(2 entities) | 86 | $10,431 |
| CSL Behring | 11 | $2,908 |
| Contego Medical, Inc | 1 | $2,000 |
| Boston Scientific | 33 | $1,908 |
| Cardiovascular Systems Inc. | 29 | $1,807 |
| Shockwave Medical, Inc | 8 | $1,109 |
| Abiomed | 10 | $1,023 |
| Philips North America LLC | 8 | $552 |
| Bolton Medical Inc | 3 | $321 |
| Abbott | 3 | $244 |
| Edwards Lifesciences | 1 | $176 |
| Penumbra, Inc. | 1 | $150 |
| Siemens Medical Solutions USA, Inc. | 1 | $143 |
| Acist Medical Systems, Inc. | 1 | $124 |
| Endologix LLC | 1 | $83 |
| Cardiva Medical, Inc. | 1 | $44 |
| Biotronik Inc. | 1 | $42 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FFRct$11,612
- Resolute$7,196
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$1,048
- Impella$754
- Coronary Orbital Atherectomy System$599
- Diamondback Coronary$481
- CoreValve Evolut$340
- COREVALVE EVOLUT R$297
- SYNERGY$276
- GENERAL - STENTS$263
- IGT D Coronary$260
- Peripheral Orbital Atherectomy System$233
- ONYX FRONTIER$225
- ACIST RXI SYSTEM$188
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$176
- AVVIGO Guidance System$167
- RESOLUTE ONYX$165
- PROMUS$150
- Penumbra System$150
- Indigo$150
How this compares
$34,677 in reported general payments places this provider in the 75th percentile of 382 interventional cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 70 | $110,752 |
| Repatha SureclickEvolocumab | 19 | $10,306 |
| Metoprolol Succinate | 127 | $2,000 |
| Ranolazine ErRanolazine | 13 | $1,195 |
| Atorvastatin Calcium | 120 | $1,123 |
| Rosuvastatin Calcium | 69 | $1,115 |
| Ezetimibe | 17 | $588 |
| ClopidogrelClopidogrel Bisulfate | 75 | $557 |
| Losartan Potassium | 61 | $554 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 13 | $399 |
| Carvedilol | 42 | $386 |
| Amlodipine Besylate | 45 | $351 |
| Omeprazole | 16 | $307 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 16 | $261 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 22 | $257 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in New York
- Sahil ParikhNew York$1.6M
- Deepak BhattNew York$1.6M
- Martin LeonNew York$1.5M
- Sripal BangaloreNew York$482K
- Ajay KirtaneNew York$462K
- Prakash KrishnanNew York$387K
- Jaikirshan KhatriNew York$307K
- Samin SharmaNew York$291K
- Torsten VahlNew York$280K
- George DangasNew York$263K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.